EcoR1 Capital, LLC bought $1.1M of ANAB
director, owner at ANAPTYSBIO, INC. 85,098 shares at an average of $12.92, traded Dec 30, 2024, filed Jan 2, 2025.
Score components
- +15RoleDirector
- +25Trade size$1.1M at market
- 0Relative to holdingsHoldings up 1.1%
- +18Price context1% above the 52-week low; 67% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000935836-25-000008, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 30, 2024 | POpen-market purchase Common Stockindirect: See Note | +65,184 | $12.92 | $842k | 7,860,180 | Jan 2, 2025 |
| Dec 31, 2024 | POpen-market purchase Common Stockindirect: See Note | +13,268 | $12.93 | $172k | 7,873,448 | Jan 2, 2025 |
| Jan 2, 2025 | POpen-market purchase Common Stockindirect: See Note | +6,646 | $12.95 | $86k | 7,880,094 | Jan 2, 2025 |
Related signals
Other insiders at ANAPTYSBIO, INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 3Weak | ANAPTYSBIO, INC | Hollings Renton director | $249k 5,000 shares | -31% | |
| 21Weak | ANAPTYSBIO, INC | Hollings Renton director | $72k 3,015 shares | -38% | |
| 21Weak | ANAPTYSBIO, INC | Dennis M Fenton director | $72k 3,015 shares | -38% | |
| 13Weak | ANAPTYSBIO, INC | Hollings Renton director | $250k 10,000 shares | -84% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.